2019 IPO
Harpoon Therapeutics Stock
Harpoon Therapeutics is a preclinical stage biotechnology company.
Sign up today and learn more about Harpoon Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Harpoon Therapeutics Stock
Harpoon Therapeutics is a preclinical stage biotechnology company founded by MPM that is developing a novel class of T cell recruiting antibodies against validated hematologic and solid tumor targets.
Funding History
April 2016 | $15.0M |
---|---|
May 2017 | $45.0M |
November 2018 | $70.0M |
Management
Vice President
Che-Leung Law
CFO
William E. Picht
Co-Founder
Luke Evnin
President & CEO
Gerald McMahon
SENIOR VICE PRESIDENT
Holger Wesche